Recent Posts

Pa. Risperdal Off-Label Trial Ends With Nonsuit For Janssen
Posted on 14 Jun 2010 by Tom Moylan

PHILADELPHIA - (Mealey's) A Pennsylvania state court judge on June 14 granted Janssen Pharmaceutica Inc.'s motion for a nonsuit of the state government's third-party payer suit alleging that the drug company's off-label marketing of its... Read More

Arkansas Judge Orders J&J Unit To Pay $1.1 Billion Penalty For Risperdal Marketing
Posted on 12 Apr 2012 by Tom Moylan

LITTLE ROCK, Ark. - (Mealey's) An Arkansas state court judge on April 11 assessed a $1.1 billion penalty against the Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson for thousands of violations of state trade practice... Read More